Logo image of RANI

RANI THERAPEUTICS HOLDINGS-A (RANI) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:RANI - US7530181004 - Common Stock

1.35 USD
-0.01 (-0.74%)
Last: 1/21/2026, 8:00:01 PM
1.33 USD
-0.02 (-1.48%)
After Hours: 1/21/2026, 8:00:01 PM
Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to RANI. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 9.44. This target is 598.89% above the current price.
  • RANI was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about RANI.
  • In the previous month the buy percentage consensus was at a similar level.
  • RANI was analyzed by 9 analysts. More opinions would make the average more meaningful.
RANI Historical Analyst RatingsRANI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -52 -47 -42 -37 -32 -27 -22 -17 -12 -7 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.357.079.699.4411.55 - 423.70% 617.78% 598.89% 755.56%
RANI Current Analyst RatingRANI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2026-01-09 HC Wainwright & Co. Reiterate Buy -> Buy
2025-10-20 Maxim Group Maintains Buy -> Buy
2025-05-16 Oppenheimer Maintains Outperform -> Outperform
2025-04-03 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-26 Canaccord Genuity Maintains Buy -> Buy
2025-02-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-19 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-16 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-02 Oppenheimer Initiate Outperform
2024-06-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-14 Maxim Group Initiate Buy
2024-06-13 Rodman & Renshaw Initiate Buy
2024-05-09 BTIG Maintains Buy -> Buy
2024-05-07 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-27 Canaccord Genuity Maintains Buy -> Buy
2024-03-25 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-06 Wedbush Reiterate Outperform -> Outperform
2023-11-09 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-21 B of A Securities Maintains Buy -> Buy
2023-08-17 Wedbush Reiterate Outperform -> Outperform
2023-08-14 HC Wainwright & Co. Maintains Buy -> Buy
2023-06-06 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-11 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-23 HC Wainwright & Co. Reiterate Buy
2022-10-11 UBS Initiate Buy
2022-07-27 HC Wainwright & Co. Initiate Buy
2022-06-13 Wedbush Initiate Outperform

RANI THERAPEUTICS HOLDINGS-A / RANI FAQ

What do analysts expect the price target to be for RANI THERAPEUTICS HOLDINGS-A (RANI)?

9 analysts have analysed RANI and the average price target is 9.44 USD. This implies a price increase of 598.89% is expected in the next year compared to the current price of 1.35.


What is the consensus rating for RANI THERAPEUTICS HOLDINGS-A (RANI) stock?

The consensus rating for RANI THERAPEUTICS HOLDINGS-A (RANI) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed RANI THERAPEUTICS HOLDINGS-A (RANI)?

The number of analysts covering RANI THERAPEUTICS HOLDINGS-A (RANI) is 9.